According to Meihua Biotech's announcement, it is expected to achieve net profit of 600 million yuan to 800 million yuan in the semi-annual year of 2026. Compared with 1,768 billion yuan in the same period last year, it is expected to decrease 970 million yuan to 1,170 million yuan, a year-on-year decrease of 55% to 66%; net profit after deducting non-recurring profit and loss of 430 million yuan to 630 million yuan, a year-on-year decrease of 61% to 74%. The pre-decline in performance was mainly due to an increase in industry supply and a year-on-year decline in the prices of the company's main products.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.